It is currently Wed Sep 02, 2015 3:42 am

News News of Tcelna (Tovaxin)

Site map of Tcelna (Tovaxin) » Forum : Tcelna (Tovaxin)

A board to discuss Tcelna as a treatment for Multiple Sclerosis

Tovaxin Users - Where are You?

No one has written on this page for over two weeks. I check it out everyday to see how the Tovaxin users are doing. How is the trial going? Does anyone know anything new?
Read more : Tovaxin Users - Where are You? | Views : 4698 | Replies : 16


European patent for Tovaxin !

Quoted from Marketwatch.com : Opexa required european patent for Tovaxin, and M. CEO seems to be interested in european development of Tovaxin. Maybe a hope for a clinical trial in Europe soon ?

<shortened url>
Read more : European patent for Tovaxin ! | Views : 1892 | Replies : 1


Struggling

I am getting impatient again with the extension. I just posted in the general discussion about recent changes in my ability to void urine and am just absolutely maddenned with my constant downhill slide this year. During this trial, I have had more stuff get worse than the five years prior combined. I know there is nothing many of us can do, but being in this trial and not getting the drug is like the ...
Read more : Struggling | Views : 2532 | Replies : 8


injection# 2

Hey All,
Although I have been trying to curb my time spent "in forum" (I am finding the less immersed I am the better my denial works), I thought I would post an update. I had my 2nd series of injections on 8/3/07. Pretty standard stuff. No site reactions either time. I do however seem to get ill post injection. A few days of flu-like symptoms and a serious case of done-in even from an ...
Read more : injection# 2 | Views : 4709 | Replies : 23


Anyone watching OPXA stock?

What in the heck is going on besides the stock market sucking right now?
Read more : Anyone watching OPXA stock? | Views : 5200 | Replies : 19


When is it done???

So after reading a bunch of confusing crud I've decided the trial is over sometime between now and hell freezing over. Also, it's when the info will be released.

Whats the real story and what does it take for fast tracking?
Read more : When is it done??? | Views : 1828 | Replies : 1


Tovaxin and fatigue

Ok so my issue with MS is fatigue. I slept today for 4 hours. I take a vitamin that helps with it but even with all the other limitations, I want the fatigue gone.

One thing I've got the impression of is MS fatigue is gone with Tovaxin. Does it eliminate fatigue? They even had an animation on their site saying that. How is everyone doing with the fatigue? Heck with doing somersaults. Is anyone ...
Read more : Tovaxin and fatigue | Views : 5569 | Replies : 28


Peptides and Re-Tests / Trials

I was wondering, Opexa have made major improvements on the efficacy of Tovaxin by increasing the number of "Peptides" used, to identify MRTC's. In each case, they did not appear to be required to go back to Phase I trials.

Does this mean, that after it has gone through Phase III, they will be able to improve the process by increasing the number of Peptides without needing to go through the 3 phases of trial ...
Read more : Peptides and Re-Tests / Trials | Views : 4517 | Replies : 16


News on the Tovaxin Extension Trials

Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin™ for Multiple Sclerosis
June 21, 2007 09:19 AM Eastern Daylight Time

<shortened url>

Effectiveness Shown in Relapsing Remitting Subjects Across Both Phase I/II Dose Escalation and Extension Trials

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today announced positive top-line data in an open-label Phase I/II extension clinical trial of the investigational ...
Read more : News on the Tovaxin Extension Trials | Views : 2240 | Replies : 4


Tovaxin news release

June 21, 2007 09:19 AM Eastern Daylight Time
Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin™ for Multiple Sclerosis
Effectiveness Shown in Relapsing Remitting Subjects Across Both Phase I/II Dose Escalation and Extension Trials

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today announced positive top-line data in an open-label Phase I/II extension clinical trial of the investigational T-cell vaccine, ...
Read more : Tovaxin news release | Views : 1966 | Replies : 4


 

Login  •  Register


Statistics

Total posts 227106 • Total topics 23948 • Total members 15285


Contact us | Terms of Service